Categories: HealthcareNews

Privia Health to Participate in the J.P. Morgan Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ARLINGTON, Va., Jan. 03, 2023 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present and participate in a Q&A session at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 beginning at 6:00 pm ET / 3:00 pm PT.

The live webcast and replay of the event, as well as the accompanying slide presentation, will be available at ir.priviahealth.com/news-and-events/events-and-presentations.

About Privia Health

Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health’s platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and the well-being of providers. For more information, visit priviahealth.com.

Contact
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841

Staff

Recent Posts

Promino Nutritional Sciences Inc. Announces that Promino(TM) Named Official Protein Drink of the Vegas Knight Hawks

Expanding U.S. sports presence as brand aligns with Las Vegas franchisesBurlington, Ontario--(Newsfile Corp. - April…

40 minutes ago

Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 17, 2025) - Medexus Pharmaceuticals (TSX: MDP)…

40 minutes ago

Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration

In the preliminary findings of a study conducted with the National Taiwan University Hospital, over…

8 hours ago

Spring Into Savings: VARON Offers Discounts on Oxygen Solutions for Allergy Season

NEW YORK, April 16, 2025 /PRNewswire/ -- As spring blooms across the country, so does allergy…

8 hours ago

Saudi Arabia and France Strengthen Health Cooperation Through Strategic Agreements in Biotech and Digital Health

PARIS, April 16, 2025 /PRNewswire/ -- On the second day of an official visit to…

8 hours ago

Beyond Medical Technologies Announces Filing of Application for Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - April 16, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT)…

12 hours ago